Dr. Karen Kuhn Ballen MD
Hematologist-Oncologist | Hematology & Oncology
55 Fruit St Yaw 7 Boston MA, 02114About
Dr. Karen Ballen is a hematologist oncologist practicing in Boston, MA. Dr. Ballen specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Manipulation of the stem cell as a target for hematologic malignancies.
- Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic--severe combined immunodeficient assay.
- Neuroendocrine carcinoma in a patient with hairy cell leukemia: a case report.
- New trends in umbilical cord blood transplantation.
- Adhesion receptor expression by CD34+ cells from peripheral blood or bone marrow
- Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature.
- Double cord blood transplants: filling a niche?
- Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.
- Advances in umbilical cord blood transplantation.
- Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.
- High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.
- The role of HLA in umbilical cord blood transplantation.
- Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
- No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation.
- The expanding frontier of hematopoietic cell transplantation.
Clinical Trials
- A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
- Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
- Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Dr. Karen Kuhn Ballen MD's Practice location
Dr. Karen Kuhn Ballen MD's reviews
Write ReviewPatient Experience with Dr. Ballen
Recommended Articles
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- Lymphoma News: Mother Gives Birth to Healthy Daughter after Chemo During Pregnancy
Chemotherapy has a reputation for its not-so-great side effects. As many people know, chemotherapy is known to cause off target symptoms for most cancer patients such as nausea and vomiting, hair loss, and extreme fatigue. In addition to the symptoms that one may experience during treatment, some of...
- Woman Who Battled Lymphoma Three Times Starts Support Group
Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
Nearby Providers
- Dr. YongLi Ji M.D. , PH.D.55 Fruit St Boston MA 02114
- Dr. Bruno Bastos M.D.44 Binney St Boston MA 02115
- Dr. Gary M. Strauss M.D.18 Acron Road Brookline Massachusetts 2445
- Prabhsimranjot Singh MD17 Faxon St Newton Massachusetts 02458
- Dr. Folefac Edmund M.D.79-81 Highland Ave. Salem MA 01970
- Dr. Susan Tinsley Schumer Other2014 Washington Street Newton Lower Falls MA 02462